MedPath

Transjugular liver biopsy for liver damage after hematopoietic stem cell trasnplantatio

Not Applicable
Recruiting
Conditions
liver damage after hematopoietic stem cell transplantation
Registration Number
JPRN-UMIN000017752
Lead Sponsor
nivesity of Tokyo Hospital, Department of Hematology and Oncology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1. Obvious cause of liver damage. 2. Can be applied to percutaneous liver biopsy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath